The ongoing coronavirus disease (COVID-19) pandemic has dramatically tested healthcare
systems around the world, with serious repercussions on the measures of prevention and …

Attention has recently been directed toward a plausible link between Clostridium difficile
infection (CDI) and proton-pump inhibitors (PPIs). However, the results of studies on the …

Clostridium difficile PCR ribotype (RT) 014 is well-established in both human and porcine
populations in Australia, raising the possibility that C. difficile infection (CDI) may have a …

Background Healthcare events related to diabetic foot disease carry a burden of morbidity,
mortality and economic cost. Prompt identification of clinical infection with appropriate tissue …

Clostridium difficile is toxin-producing antimicrobial resistant (AMR) enteropathogen
historically associated with diarrhea and pseudomembranous colitis in hospitalized patients …

Clostridioides difficile infection (CDI) has emerged as a major health problem worldwide. A
major risk factor for disease development is prior antibiotic use, which disrupts the normal …

The epidemiology and transmission of Clostridioides difficile, particularly for community-
associated infections, are not completely understood. Although there have been no …

Clostridioides difficile is one of the most important causes of healthcare-associated diarrhea.
The high incidence and recurrence rates of C. difficile infection, as well as its associated …

Clostridioides difficile (C. difficile) is responsible for a high percentage of gastrointestinal
infections and its pathological activity is due to toxins A and BC difficile infection (CDI) is …

Abstract Introduction The prevalence of Clostridium difficile infection is rapidly increasing
worldwide, but prevalence is difficult to estimate in developing countries where awareness …